BLS — BLS Pharmaceuticals Share News
0.000.00%
- AU$255.28m
- AU$250.42m
- AU$74.23m
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:03:00
Australia Stock Exchange release from BIOXYNE : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from BIOXYNE : Results of Meeting
Australia Stock Exchange release from BIOXYNE : Reinstatement to Official Quotation
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 09:11:07
Australia Stock Exchange release from BIOXYNE : Bioxyne Not to Proceed with Proposed Acquisition
Australia Stock Exchange release from BIOXYNE : Letter to Shareholders on Annual General Meeting
Australia Stock Exchange release from BIOXYNE : Notice of Annual General Meeting/Proxy Form
Australia Stock Exchange release from BIOXYNE : Suspension from Quotation
Australia Stock Exchange release from BIOXYNE : Trading Halt Remains
Australia Stock Exchange release from BIOXYNE : Quarterly Activities/Appendix 4C Cash Flow Report
Brief: Bioxyne Trading Halt
Australia Stock Exchange release from BIOXYNE : Trading Halt
Australia Stock Exchange release from BIOXYNE : Pause in Trading
Australia Stock Exchange release from BIOXYNE : Appendix 4G and Corporate Governance Statement
Australia Stock Exchange release from BIOXYNE : Annual Report to shareholders
Australia Stock Exchange release from BIOXYNE : PRE_NR Ends: 16:47:12
Australia Stock Exchange release from BIOXYNE : Explanatory Note to the 2021 Annual Report
Australia Stock Exchange release from BIOXYNE : Preliminary Final Report